Is symptom duration before DMARD therapy a determinant of direct and indirect costs in DMARD-naïve RA patients? A systematic review

OBJECTIVE: Early treatment of RA improves clinical outcomes; however, the impact on health economic outcomes is unclear. This review sought to investigate the relationship between symptom/disease duration and resource utilization/costs and the responsiveness of costs following RA diagnosis. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Sahbudin, Ilfita, Singh, Ruchir, Trickey, Jeanette, Baranskaya, Aliaksandra, Tracy, Alexander, Raza, Karim, Filer, Andrew, Jowett, Sue, Boonen, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Systematic Review and Meta-Analysis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185403/
https://www.ncbi.nlm.nih.gov/pubmed/37197378
http://dx.doi.org/10.1093/rap/rkad040

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10185403/
https://www.ncbi.nlm.nih.gov/pubmed/37197378
http://dx.doi.org/10.1093/rap/rkad040

Ejemplares similares